GLP-1 Weight Loss Drugs Linked to Lower Breast Cancer Risk
Researchers report that women using GLP-1 receptor agonists were significantly less likely to develop breast cancer, adding to growing evidence that the drugs m...
Researchers report that women using GLP-1 receptor agonists were significantly less likely to develop breast cancer, adding to growing evidence that the drugs may have benefits beyond weight loss and diabetes management. The post GLP-1 Weight Loss Drugs Linked to Lower Breast Cancer Risk appeared first on Inside Precision Medicine .